Thus, maintaining GPNMB expression in glaucomatous RGCs could halt RGC death and optic nerve degeneration, and GPNMB could be a common therapeutic target enhancing neuroprotection and axon regeneration in neurodegenerative diseases and after nerve injury. The gene discussed is GPNMB; the disease is neurodegenerative disease.